Epitomics Inc.

Abcam Burlingame

UEI
GHX3CZALWZT9
CAGE
3CSP6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
abcam.com
Founded
1998
Employees
1K-5K
Estimated annual revenue
$250M-$500M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Epitomics Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Production of 2 antibodies directed against phospho-RECQL4 SER89 and phospho-RECQL4 SER251 Contract · 75N91018P00646 National Cancer Institute $4,932
Abcam INC:1106175 [18-034237] Contract · 75N91018P00317 National Cancer Institute $4,657
Service drugs and biologicals Contract · HHSN261201800059PC National Cancer Institute $8,254
Epitomics INC:1110226 [17-013522] the period of performance is 9/12/17 - 9/11/18. For invoice questions contact… Contract · HHSN275201700877P National Institute of Child Health and Human Development $4,702
Rabbit monoclonal antibody production to mouse TMC6 and mouse TMC8 Contract · HHSN261201600796P National Cancer Institute $0

Quick answers

What is Epitomics Inc.'s UEI?

Epitomics Inc.'s Unique Entity ID (UEI) in SAM.gov is GHX3CZALWZT9.

What is Epitomics Inc.'s CAGE code?

Epitomics Inc.'s CAGE code is 3CSP6.

What is Epitomics Inc.'s primary NAICS code?

Epitomics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Epitomics Inc. registered in SAM.gov?

Epitomics Inc.'s SAM.gov registration expired on January 9, 2025.

What is Epitomics Inc.'s most recent federal award?

Epitomics Inc.'s most recent federal contract award is Production of 2 antibodies directed against phospho-RECQL4 SER89 and phospho-RECQL4 SER251 (75N91018P00646), from National Cancer Institute, on August 23, 2018.

On GovTribe

See Epitomics Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login